Stanton is handling the deal for Diversey as the Bain Capital-backed hygiene, infection prevention and cleaning products company “goes private” following a $4.6B merger with Solenis special chemical producer.
Phil Wieland, Diversey CEO, said the merger is an opportunity “to create a more diversified business with increased scale, broader global reach, and superior customer service capabilities."
The combined company “will provide a number of attractive cross-selling opportunities, including meeting increasing customer demand for water management, cleaning and hygiene solutions,” he added.
Diversey shareholders will receive $8.40 in cash for their shares. That represents a 41 percent premium over the March 7 closing stock price.
Stanton’s Charlyn Lusk and Scott Lessne are working the deal.